|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 35/768 | |
| C07K 16/18 |
| (11) | Patento numeris | 3169341 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15738359.7 |
| Europos patento paraiškos padavimo data | 2015-07-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-05-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-06-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2015/066263 |
| Data | 2015-07-16 |
| (87) | Numeris | WO 2016/008976 |
| Data | 2016-01-21 |
| (30) | Numeris | Data | Šalis |
| 14306153 | 2014-07-16 | EP |
| (72) |
SILVESTRE, Nathalie, FR
GEIST, Michel, FR
RITTNER, Karola, FR
MARCHAND, Jean-Baptiste, FR
THIOUDELLET, Christine, FR
|
| (73) |
Transgene SA,
Parc d`Innovation Boulevard Gonthier d`Andernach, 67400 Illkirch Graffenstaden,
FR
|
| (54) | ONCOLYTIC VIRUS FOR EXPRESSION OF IMMUNE CHECKPOINT MODULATORS |
| ONCOLYTIC VIRUS FOR EXPRESSION OF IMMUNE CHECKPOINT MODULATORS |